David Silberman - Jan 4, 2024 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Chief Financial Officer
Signature
/s/ David Silberman
Stock symbol
ORMP
Transactions as of
Jan 4, 2024
Transactions value $
$0
Form type
4
Date filed
1/8/2024, 04:39 PM
Previous filing
May 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +137K +59.35% 367K Jan 4, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 11,375 over a three year period starting January 8, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.